Email not displaying properly? View email in your browser

Advertise   |    Archives

Merck Merck Invests €50 Million in Pharmaceutical Packaging Building in Darmstadt, Germany

Merck, a leading science and technology company, announced an investment of more than €50 million in a state-of-the-art packaging building at its pharmaceutical manufacturing site in Darmstadt, Germany.With its state-of-the art, flexible and modern technology, this new center of excellence will enable the packaging of more than 400 million blisters or 150 million packs annually. It will use energy-saving technologies,and forms part of Merck’s strategy to sustainably secure its leading position... more...

Featured Products
Fluid-Bag Multi
Fluid-Bag Multi
The Multi containers combine the flexibility and space saving advantages of both single-trip and multitrip containers.The containers (900 and 1000 litres) consist of a replaceable, single-trip inner container.a reusable multi-trip transport bag.a reusable steel transport pallet with 4 steel poles.


NeoTOP x
NeoTOP x
As a result of the increasing market and product segmentation, in addition to the way the modern medicines work, the prevalent extensive variety of secondary packaging is constantly expanding. This is why the flexibility and over-all efficiency of the packaging process is of paramount...


R-3-Quinuclidinol is an advanced chiral intermediate that is used in the synthesis of API Solifenacin succinate. We offer this product from Synkem Corden Pharma, France. R-3-Quinuclidinol product is manufactured by an enzymatic route, it shows a higher enantiomeric purity than the...


Industry Updates
RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc
RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc. RXi Pharmaceuticals Corp - can exercise option to acquire Mirimmune on terms set forth in option agreement at any time prior to April 5, 2017. RXi Pharmaceuticals Corp - deal for number of shares equal...
Press Releases
Daiichi Sankyo and Dana-Farber Cancer Institute Announce Lung Cancer Research Collaboration
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and the Dana-Farber Cancer Institute today announced a preclinical research collaboration focused on lung cancer.A team of scientists led by Pasi A. Jänne, MD, PhD, Director, Lowe Center for...
Events and Exhibitions
Evidence US 2016
18th Oct 2016 - 19th October 2016

Hilton Philadelphia City Avenue, Philadelphia,
Microfluidics Congress 2016
20th Oct 2016- 21st Oct 2016

Radisson Blu Edwardian Heathrow, London
Subscribe Unsubscribe Advertise Archives – a product of Ochre Media Pvt. Ltd.
Ochre Media Pvt Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555
" width="1" height="1" border="0">